FULLY FUNDED TERTIARY QUALIFICATION LAUNCHES TO ADDRESS PERINATAL MENTAL HEALTH CLINICIAN SHORTAGE IN AUSTRALIAN-FIRST Tertiary qualification launched by Gidget Foundation and Federation University.
With Arabella Gibson, CEO
Gidget Foundation Australia
SEGMENT
Filmed in North Sydney | January 2025
Demand for perinatal mental health services is continuing to surge year-on-year. In fact, perinatal mental health organisation, Gidget Foundation Australia (GFA), has supported 30% more clients in FY2024 than in FY2023, up by 214% since FY2021.
Perinatal depression and anxiety (PNDA) impacts 100,000 Australians each year, equating to one in five mums and one in ten dads, with PNDA costing Australia $877 million annually. To address the nationwide shortage of specialist perinatal mental health clinicians, Gidget Foundation Australia has partnered with Federation University to launch the Graduate Diploma in Perinatal Mental Health.
Australian Health Journal met with Arabella Gibson, CEO Gidget Foundation Australia following the announcement to hear about the Gidget mission and the new initiative to address the perinatal mental health clinician shortage.
The new Graduate Diploma in Perinatal Mental Health creates a unique offering in the industry, providing comprehensive ‘on the job’ training, weekly supervision for clinicians, academic modules and a paid placement opportunity as well as ongoing employment through Gidget Foundation Australia’s face-to-face or telehealth services.
The new partnership, create an Australian-first offering of a fully supported tertiary qualification. Gidget Foundation Australia and Federation University have engaged in the unique co-design and co-delivery of the qualification, with both organisations developing and delivering practical and theoretical course content.
Ms Gibson says the Gidget Foundation, with Federation University, is committed to ensuring robust clinical standards are achieved through providing exceptional education for clinicians working in the perinatal space.
“We’ve seen demand for perinatal depression and anxiety support continue to rise, our clinicians supported 30% more clients in FY2024 than in FY2023. It’s essential we have enough qualified clinicians to meet this growing demand to address the critical needs of the individuals impacted.
“Equity, access, and affordability can be a barrier for allied health professionals to further extend their professional knowledge and skills. The Graduate Diploma in Perinatal Mental Health enables health professionals to upskill in perinatal and infant mental health and creates an accessible pathway to enhance knowledge and experience across the sector; whilst benefitting the health professional, clients, and the wider community.”, says Ms Gibson.
The first cohort of the new Graduate Diploma in Perinatal Mental Health will graduate in July 2025 and applications opened in November 2024 for the February 2025 intake.
-
CASE STUDY: Creating awareness, workforce education & dissemination strategy in national screening
At the recent Screening Conference 2025 in Sydney, hosted by Public Health Association, Dr Rachael Dodd, Senior Research Fellow at The Daffodil Centre, spoke about the information and educational resources created to increase awareness in the healthcare workforce and community on the upcoming Australia’s National Lung Cancer Screening Program commencing in July 2025.
-
Landmark brain shape study
For over a century, researchers have thought that the patterns of brain activity that define our experiences, hopes and dreams are determined by how different brain regions communicate with each other through a complex web of trillions of cellular connections.
Now, a Monash University Turner Institute for Brain and Mental Health-led study has examined more than 10,000 different maps of human brain activity and found that the overall shape of a person’s brain exerts a far greater influence on how we think, feel and behave than its intricate neuronal connectivity.
-
Australian Teletrial Program reaches significant milestones in trials and participants
Launched in 2022, the Australian Teletrial Program is an initiative designed to improve access to clinical trials for people living in regional and remote areas of Australia. It uses telemedicine and digital technologies to enable patients to participate in clinical trials without needing to travel long distances to major metropolitan centres, which can often be a barrier to participation for those in rural and isolated locations.
Recently Australian Health Journal met with Kaye Hewson, Director, Australian Teletrials Program, who spoke about the program’s recent achievements.
